GITNUX MARKETDATA REPORT 2024

Cannabinoid Hyperemesis Syndrome Recovery Time Statistics

On average, recovery time for Cannabinoid Hyperemesis Syndrome ranges from 1 to 3 months after cessation of cannabis use.

In this post, we will explore the latest statistics surrounding Cannabinoid Hyperemesis Syndrome (CHS) recovery time and prevalence. From the number of individuals affected annually in the United States to the success rates of certain recovery programs, we will delve into the data to better understand this condition and its impact on those who use cannabis regularly.

Statistic 1

"A 2020 study reported that approximately 2.75 million people in the United States may suffer from Cannabinoid Hyperemesis Syndrome (CHS) annually."

Sources Icon

Statistic 2

"According to SameDay Health research, approximately 90% of patients using Comprehensive Recovery Therapy (CRT) program get symptom free from CHS within 3 weeks."

Sources Icon

Statistic 3

"According to a study of 2177 cases, the median prevalence of CHS was about 32.9% of patients with chronic cannabis use."

Sources Icon

Statistic 4

"Regularly using cannabis increases your risk of Cannabinoid Hyperemesis Syndrome by almost three times."

Sources Icon

Statistic 5

"A study found that duration of cannabis use before onset of CHS symptoms was an average of 16.3 years."

Sources Icon

Statistic 6

"According to the Mayo Clinic, repeated emergency room visits before CHS diagnosis are common, with people having symptoms for several years before CHS is accurately diagnosed."

Sources Icon

Statistic 7

"A study indicated that the amount of daily cannabis use among patients with CHS was quite high, with the median use being 5 times per day."

Sources Icon

Statistic 8

"Male patients were slightly more likely to be affected by CHS (about 54.4%) compared to females (45.6%)."

Sources Icon
In conclusion, the statistics reveal important insights into Cannabinoid Hyperemesis Syndrome (CHS), a condition associated with chronic cannabis use. The data suggest a significant prevalence of CHS among cannabis users in the United States, with a high likelihood of symptom resolution within 3 weeks through Comprehensive Recovery Therapy. The findings also highlight the long-term risks of CHS, such as increased likelihood with regular cannabis use and delayed diagnosis despite repeated emergency room visits. Understanding these statistics can inform healthcare providers and individuals about the potential challenges and recovery pathways associated with CHS.

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!